Shares of IMS Health Holdings Inc. (NYSE:IMS) have been assigned an average recommendation of “Buy” from the ten analysts that are presently covering the stock. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $31.00.
A number of brokerages recently commented on IMS. Zacks Investment Research raised IMS Health Holdings from a “hold” rating to a “buy” rating and set a $34.00 price objective for the company in a research note on Wednesday, September 28th. TheStreet cut IMS Health Holdings from a “buy” rating to a “hold” rating in a research note on Monday, August 29th.
IMS Health Holdings (NYSE:IMS) remained flat at $31.34 during midday trading on Monday. IMS Health Holdings has a one year low of $22.36 and a one year high of $31.59. The company has a market cap of $10.32 billion, a PE ratio of 76.07 and a beta of 0.83. The stock has a 50-day moving average of $29.78 and a 200-day moving average of $27.31.
IMS Health Holdings (NYSE:IMS) last announced its quarterly earnings data on Wednesday, July 27th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.03. IMS Health Holdings had a return on equity of 30.61% and a net margin of 4.45%. The business earned $802 million during the quarter, compared to analysts’ expectations of $796.93 million. During the same period in the previous year, the firm earned $0.37 earnings per share. The firm’s quarterly revenue was up 112.4% compared to the same quarter last year. On average, equities research analysts anticipate that IMS Health Holdings will post $1.64 EPS for the current year.
Several hedge funds have recently modified their holdings of the stock. CIBC Asset Management Inc raised its stake in shares of IMS Health Holdings by 1.0% in the second quarter. CIBC Asset Management Inc now owns 13,182 shares of the company’s stock worth $334,000 after buying an additional 127 shares during the period. Sumitomo Mitsui Asset Management Company LTD raised its stake in shares of IMS Health Holdings by 1.9% in the second quarter. Sumitomo Mitsui Asset Management Company LTD now owns 11,293 shares of the company’s stock worth $286,000 after buying an additional 212 shares during the period. Calvert Investment Management Inc. raised its stake in shares of IMS Health Holdings by 3.9% in the second quarter. Calvert Investment Management Inc. now owns 8,220 shares of the company’s stock worth $208,000 after buying an additional 310 shares during the period. Nordea Investment Management AB raised its stake in shares of IMS Health Holdings by 9.3% in the second quarter. Nordea Investment Management AB now owns 4,811 shares of the company’s stock worth $122,000 after buying an additional 411 shares during the period. Finally, Oppenheimer & Co. Inc. raised its stake in shares of IMS Health Holdings by 3.0% in the second quarter. Oppenheimer & Co. Inc. now owns 14,926 shares of the company’s stock worth $379,000 after buying an additional 433 shares during the period. Institutional investors own 90.25% of the company’s stock.
IMS Health Holdings Company Profile
IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
Receive News & Ratings for IMS Health Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.